FindTrial
Sign In

Investigation of adverse events in long-term administration of vonoprazan for patients with gastroesophageal reflux disease

Investigation of adverse events in long-term administration of vonoprazan for patients with gastroesophageal reflux disease - Investigation of adverse events in long-term administration of vonoprazan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021419
Enrollment
Unknown
Registered
2016-03-10
Start date
2016-03-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease

Interventions

None listed

Sponsors

Aichi medical university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with gastroesophageal reflux disease having possibility of taking vonoprazan for long-term.

Exclusion criteria

Exclusion criteria: The patients having contraindication of vonoprazan administratioon.

Design outcomes

Primary

MeasureTime frame
Incidence of malignant tumor.—

Countries

Japan

Contacts

Public ContactHisatsugu Noda

Aichi medical university school of medicine gastroenterology

bisaipan@aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026